Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids
Open accessThe DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
Taking into consideration that glucocorticoid (GC) hormones have been used clinically for over half a century and that more than 20 yr have passed since the cloning of the GC receptor (GR), it is hard to imagine that novel aspects in the molecular mechanism by which GCs mediate their antiinflammatory actions are still being unveiled today. Partly, this is because almost on a daily basis, novel insights arise from parallel fields, e.g. nuclear receptor cofactor and chromatin regulation and their concomitant impact on gene transcription events, eventually leading to a revisitation or refinement of old hypotheses. On the other hand, it does remain striking and puzzling why GCs use different mechanisms in so many different cell types and on many different target genes to elicit an antiinflammatory effect. Meanwhile, the obvious question for the clinic remains: is the separation of GR functionalities through differential ligand design the strategy of choice to avoid most GC-mediated side effects? This minireview aims to highlight some of the latest findings on aspects of the antiinflammatory working mechanisms of GCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A failure in GR function, as hypothesized to take place in depression, may therefore result from reduced glucocorticoid binding to GR, reduced GR expression, enhanced activation of inflammatory pathways, or lack of co-repressor activity”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as De Bosscher and Haegeman, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., & Evans, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90397-w · Cited by 1,221
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Self-citationScheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
Vermeulen, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg139 · Cited by 760
Self-citationIto, K., Barnes, P. J., & Adcock, I. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6891-6903.2000 · Cited by 723
Alexander, W. S., & Hilton, D. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.091003.090312 · Cited by 701
p38-dependent marking of inflammatory genes for increased NF-κB recruitment
Saccani, S., Pantano, S., & Natoli, G. (2002) · Nature Immunology · doi:10.1038/ni748 · Cited by 693
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638 · cited 1×
“Indeed, by targeting acetylated GR, HDAC2 is capable of potentiating the inhibitory effect of GCs (90).”
BackgroundGene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O’shea, J. J., Chrousos, G. P., & Bornstein, S. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0245com · Cited by 606 · cited 1×
“ing and suppressive effects of GCs on immune cells (82).”
BackgroundThe Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Sar, M., & Cidlowski, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9550 · Cited by 562
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., & Cato, A. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 522
Molecular mechanisms of glucocorticoid action: what is important?
Newton, R. (2000) · Thorax · doi:10.1136/thorax.55.7.603 · Cited by 510
MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14
Soloaga, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg273 · Cited by 505
Nuclear Receptor Coregulators: Judges, Juries, and Executioners of Cellular Regulation
Lonard, D. M., & O'Malley, B. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.012 · Cited by 494
Lu, N. Z., & Cidlowski, J. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.025 · Cited by 455
TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme
Verstrepen, L., Bekaert, T., Chau, T.-L., Tavernier, J., Chariot, A., & Beyaert, R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8064-8 · Cited by 440
Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., & Clark, A. R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060336 · Cited by 430 · cited 14×
“First Published Online December 18, 2008 Abbreviations: AP-1, Activating protein 1; COX, cyclooxygenase; CREB, cAMP response element-binding protein; DEX, dexamethasone; GC, glucocorticoid; GILZ, GC-induced leucine zipper; GR, GC receptor; GRE, GC response element; GRIP1, GR-interacting protein 1; HDAC, histone deacet…”
BackgroundInfluentialRepression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429
Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists
Stahn, C., Löwenberg, M., Hommes, D. W., & Buttgereit, F. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.019 · Cited by 419
Molecular mechanisms of glucocorticoid action and resistance
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00263-7 · Cited by 416
MAPK-regulated transcription: a continuously variable gene switch?
Hazzalin, C. A., & Mahadevan, L. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm715 · Cited by 400
Update on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 397
MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock
Zhao, Q., Wang, X., Nelin, L. D., Yao, Y., Matta, R., Manson, M. E., Baliga, R. S., Meng, X., Smith, C. V., Bauer, J. A., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051794 · Cited by 370
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Morand, E. F., Leech, M., & Bernhagen, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2029 · Cited by 351
Thioredoxin-Interacting Protein
Chen, J., Saxena, G., Mungrue, I. N., Lusis, A. J., & Shalev, A. (2008) · Diabetes · doi:10.2337/db07-0715 · Cited by 350
Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses
Salojin, K. V., Owusu, I. B., Millerchip, K. A., Potter, M., Platt, K. A., & Oravecz, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1899 · Cited by 337
Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
Caelles, C., González-Sancho, J. M., & Muñoz, A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3351 · Cited by 334
Newton, R., & Holden, N. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038794 · Cited by 328
Wang, J.-C., Derynck, M. K., Nonaka, D. F., Khodabakhsh, D. B., Haqq, C., & Yamamoto, K. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407008101 · Cited by 320
Interaction of the Glucocorticoid Receptor with the Chromatin Landscape
John, S., Sabo, P. J., Johnson, T. A., Sung, M.-H., Biddie, S. C., Lightman, S. L., Voss, T. C., Davis, S. R., Meltzer, P. S., Stamatoyannopoulos, J. A., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.010 · Cited by 311
Vayssière, B. M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., & Resche-Rigon, M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9979 · Cited by 311
Determinants of Cell- and Gene-Specific Transcriptional Regulation by the Glucocorticoid Receptor
So, A. Y.-L., Chaivorapol, C., Bolton, E. C., Li, H., & Yamamoto, K. R. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030094 · Cited by 305
Inhibition of AP-1 by the Glucocorticoid-inducible Protein GILZ
Mittelstadt, P. R., & Ashwell, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101522200 · Cited by 301
Corticosteroids: The drugs to beat
Barnes, P. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.052 · Cited by 301
Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression
Chen, W., Dang, T., Blind, R. D., Wang, Z., Cavasotto, C. N., Hittelman, A. B., Rogatsky, I., Logan, S. K., & Garabedian, M. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0219 · Cited by 280
Hittelman, A. B. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5380 · Cited by 276
Anti-inflammatory functions of glucocorticoid-induced genes
Clark, A. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.013 · Cited by 274
Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification
Duma, D., Jewell, C. M., & Cidlowski, J. A. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.009 · Cited by 267
Webster, J. C., Jewell, C. M., Bodwell, J. E., Munck, A., Sar, M., & Cidlowski, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9287 · Cited by 261
A fully dissociated compound of plant origin for inflammatory gene repression
De Bosscher, K., Berghe, W. V., Beck, I. M. E., Van Molle, W., Hennuyer, N., Hapgood, J., Libert, C., Staels, B., Louw, A., & Haegeman, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505554102 · Cited by 260
Self-citationGlucocorticoid receptor isoforms generate transcription specificity
Lu, N. Z., & Cidlowski, J. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.005 · Cited by 248
Cross-talk between nuclear receptors and nuclear factor κB
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209935 · Cited by 247
Self-citationRogatsky, I., Luecke, H. F., Leitman, D. C., & Yamamoto, K. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262671599 · Cited by 226
A Novel Antiinflammatory Maintains Glucocorticoid Efficacy with Reduced Side Effects
Coghlan, M. J., Jacobson, P. B., Lane, B., Nakane, M., Lin, C. W., Elmore, S. W., Kym, P. R., Luly, J. R., Carter, G. W., Turner, R., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0355 · Cited by 224
Schäcke, H., Berger, M., Rehwinkel, H., & Asadullah, K. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.014 · Cited by 223
Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor
Savory, J. G. A., Hsu, B., Laquian, I. R., Giffin, W., Reich, T., Haché, R. J. G., & Lefebvre, Y. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1025 · Cited by 222 · cited 1×
“receptor between the two cellular compartments occurs (11).”
BackgroundLuecke, H. F., & Yamamoto, K. R. (2005) · Genes & Development · doi:10.1101/gad.1297105 · Cited by 217
Tuckermann, J. P., Reichardt, H. M., Arribas, R., Richter, K. H., Schütz, G., & Angel, P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.7.1365 · Cited by 196
Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions
Weigel, N. L., & Moore, N. L. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0101 · Cited by 196
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression
Löwenberg, M., Verhaar, A. P., van den Brink, G. R., & Hommes, D. W. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.02.001 · Cited by 189
Belvisi, M. G., Wicks, S. L., Battram, C. H., Bottoms, S. E. W., Redford, J. E., Woodman, P., Brown, T. J., Webber, S. E., & Foster, M. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1975 · Cited by 186
Ayroldi, E., Zollo, O., Macchiarulo, A., Di Marco, B., Marchetti, C., & Riccardi, C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7929-7941.2002 · Cited by 183
Hermoso, M. A., Matsuguchi, T., Smoak, K., & Cidlowski, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4743-4756.2004 · Cited by 176
Eddleston, J., Herschbach, J., Wagelie-Steffen, A. L., Christiansen, S. C., & Zuraw, B. L. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.027 · Cited by 171
Rogatsky, I. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6071 · Cited by 170
Molecular Identification and Characterization of A and B Forms of the Glucocorticoid Receptor
Yudt, M. R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.7.1093 · Cited by 164
Glucocorticoids in the regulation of transcription factors that control cytokine synthesis
Liberman, A. C., Druker, J., Perone, M. J., & ARZT, E. S. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.005 · Cited by 148
Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
Humphrey, E. L., Williams, J. H. H., Davie, M. W. J., & Marshall, M. J. (2006) · Bone · doi:10.1016/j.bone.2005.10.004 · Cited by 139
Dewint, P., Gossye, V., De Bosscher, K., Vanden Berghe, W., Van Beneden, K., Deforce, D., Van Calenbergh, S., Müller-Ladner, U., Vander Cruyssen, B., Verbruggen, G., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2608 · Cited by 137
Self-citationChinenov, Y., & Rogatsky, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.014 · Cited by 133 · cited 2×
“It is in this respect important to note that in the complex transcriptional networks stimulated by both TLRs and GCs various other cross talk mechanisms have been identified that cosupport the emerging role of GR in the regulation of innate immunity (84).”
BackgroundMarco, B. D., Massetti, M., Bruscoli, S., Macchiarulo, A., Virgilio, R. D., Velardi, E., Donato, V., Migliorati, G., & Riccardi, C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1080 · Cited by 131
Liberman, A. C., Refojo, D., Druker, J., Toscano, M., Rein, T., Holsboer, F., & Arzt, E. (2007) · The FASEB Journal · doi:10.1096/fj.06-7452com · Cited by 124
Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes
Blind, R. D., & Garabedian, M. J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.01.002 · Cited by 120 · cited 1×
“For example, GR phosphoisoforms have recently been found to selectively occupy promoters of some GR target genes but not of others (23).”
BackgroundWang, Z., Rong, Y., Malone, M. H., Davis, M. C., Zhong, F., & Distelhorst, C. (2005) · Oncogene · doi:10.1038/sj.onc.1209218 · Cited by 115
Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage?
Turner, J. D., Schote, A. B., Macedo, J. A., Pelascini, L. P. L., & Muller, C. P. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.005 · Cited by 114
Adams, M., Meijer, O. C., Wang, J., Bhargava, A., & Pearce, D. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0305 · Cited by 113 · cited 6×
“As a final example, macrophage migration inhibitory factor (MIF), a GC-inducible proinflammatory cytokine, has been implicated in the pathogenesis of both rheumatoid arthritis and atherosclerosis (59).”
BackgroundInfluentialItani, O. A., Auerbach, S. D., Husted, R. F., Volk, K. A., Ageloff, S., Knepper, M. A., Stokes, J. B., & Thomas, C. P. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00085.2001 · Cited by 112
Cross Talk of Signaling Pathways in the Regulation of the Glucocorticoid Receptor Function
Davies, L., Karthikeyan, N., Lynch, J. T., Sial, E.-A., Gkourtsa, A., Demonacos, C., & Krstic-Demonacos, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0360 · Cited by 109
Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF‐κB inhibition
Beck, I. M. E., Berghe, W. V., Vermeulen, L., Bougarne, N., Cruyssen, B. V., Haegeman, G., & Bosscher, K. D. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.95 · Cited by 109
Self-citationBerghe, W. V., Francesconi, E., Bosscher, K. D., Resche-Rigon, M., & Haegeman, G. (1999) · PubMed · Cited by 108
Self-citationBosscher, K. D., Craenenbroeck, K. V., Meijer, O. C., & Haegeman, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.076 · Cited by 106
Self-citationRider, L. G., Hirasawa, N., Santini, F., & Beaven, M. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2374 · Cited by 105
Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ
Bhalla, V., Soundararajan, R., Pao, A. C., Li, H., & Pearce, D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00061.2006 · Cited by 103
Differential Activities of Glucocorticoid-induced Leucine Zipper Protein Isoforms
Soundararajan, R., Wang, J., Melters, D. P., & Pearce, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707287200 · Cited by 100
Tao, Y., Williams-Skipp, C., & Scheinman, R. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000526200 · Cited by 97
Fürst, R., Schroeder, T., Eilken, H. M., Bubik, M. F., Kiemer, A. K., Zahler, S., & Vollmar, A. M. (2007) · The FASEB Journal · doi:10.1096/fj.06-6752com · Cited by 95
Glucocorticoid Repression of AP-1 Is Not Mediated by Competition for Nuclear Coactivators
De Bosscher, K. (2001) · Molecular Endocrinology · doi:10.1210/me.15.2.219 · Cited by 95
Self-citationGlucocorticoid Effects on NF-κB Binding in the Transcription of the ICAM-1 Gene
Lidén, J., Rafter, I., Truss, M., Gustafsson, J.-Α., & Okret, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3079 · Cited by 94
Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity
Wang, J.-C., Shah, N., Pantoja, C., Meijsing, S. H., Ho, J. D., Scanlan, T. S., & Yamamoto, K. R. (2006) · Genes & Development · doi:10.1101/gad.1400506 · Cited by 94
Annexin 1, Glucocorticoids, and the Neuroendocrine–Immune Interface
BUCKINGHAM, J. C., JOHN, C. D., SOLITO, E., TIERNEY, T., FLOWER, R. J., CHRISTIAN, H., & MORRIS, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.002 · Cited by 87
McCoy, C. E., Carpenter, S., Pålsson-McDermott, E. M., Gearing, L. J., & O'Neill, L. A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709731200 · Cited by 82
So, A. Y.-L., Cooper, S. B., Feldman, B. J., Manuchehri, M., & Yamamoto, K. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801551105 · Cited by 82
Jee, Y.-K., Gilmour, J., Kelly, A., Bowen, H., Richards, D., Soh, C., Smith, P., Hawrylowicz, C., Cousins, D., Lee, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503659200 · Cited by 80
Ricketson, D., Hostick, U., Fang, L., Yamamoto, K. R., & Darimont, B. D. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.057 · Cited by 76
Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives
Chikanza, I. C. (2004) · Rheumatology · doi:10.1093/rheumatology/keh333 · Cited by 76
Chivers, J. E., Gong, W., King, E. M., Seybold, J., Mak, J. C., Donnelly, L. E., Holden, N. S., & Newton, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025841 · Cited by 74
Coregulators: transducing signal from transcription to alternative splicing
Auboeuf, D., Batsché, É., Dutertre, M., Muchardt, C., & O’Malley, B. W. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.02.003 · Cited by 72
The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438
Owen, H. C., Miner, J. N., Ahmed, S. F., & Farquharson, C. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.11.006 · Cited by 69
New and improved glucocorticoid receptor ligands
Miner, J. N., Hong, M. H., & Negro-Vilar, A. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.12.1527 · Cited by 68
DAX1: Increasing complexity in the roles of this novel nuclear receptor
McCabe, E. R. B. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.017 · Cited by 65
Carrigan, A., Walther, R. F., Salem, H. A., Wu, D., Atlas, E., Lefebvre, Y. A., & Haché, R. J. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m602931200 · Cited by 62
Impact of post-translational modifications of proteins on the inflammatory process
Ito, K. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350281 · Cited by 61
Glucocorticoid Receptor Activation of the IκBα Promoter within Chromatin
Deroo, B. J., & Archer, T. K. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.11.3365 · Cited by 61
Diefenbacher, M., Sekula, S., Heilbock, C., Maier, J. V., Litfin, M., van Dam, H., Castellazzi, M., Herrlich, P., & Kassel, O. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0574 · Cited by 58
The Ligand Binding Domain Controls Glucocorticoid Receptor Dynamics Independent of Ligand Release
Meijsing, S. H., Elbi, C., Luecke, H. F., Hager, G. L., & Yamamoto, K. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01570-06 · Cited by 58
Molecular genetic dissection of glucocorticoid receptor function in vivo
Reichardt, H. M., Tuckermann, J. P., Bauer, A., & Schütz, G. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/s003930070001 · Cited by 57
Islam, K. N., & Mendelson, C. R. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0412 · Cited by 56
Wei, P. (1998) · Molecular Endocrinology · doi:10.1210/me.12.9.1322 · Cited by 56
Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells
Reisman, D., & Thompson, E. A. (1995) · Molecular Endocrinology · doi:10.1210/me.9.11.1500 · Cited by 54
LGD-5552, an Antiinflammatory Glucocorticoid Receptor Ligand with Reduced Side Effects, in Vivo
López, F. J., Ardecky, R. J., Bebo, B., Benbatoul, K., De Grandpre, L., Liu, S., Leibowitz, M. D., Marschke, K., Rosen, J., Rungta, D., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1353 · Cited by 53
Riccardi, C., Bruscoli, S., Ayroldi, E., Agostini, M., & Migliorati, G. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0685-0_5 · Cited by 53
Horie‐Inoue, K., Takayama, K., Bono, H. U., Ouchi, Y., Okazaki, Y., & Inoue, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.188 · Cited by 52
Glucocorticoid suppression of CX 3 CL1 (fractalkine) by reduced gene promoter recruitment of NF‐κB
Bhavsar, P. K., Sukkar, M. B., Khorasani, N., Lee, K., & Fan Chung, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-094235 · Cited by 51
Bladh, L.-G., Lidén, J., Dahlman-Wright, K., Reimers, M., Nilsson, S., & Okret, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005801 · Cited by 49
Vanden Berghe, W., Francesconi, E., De Bosscher, K., Resche-Rigon, M., & Haegeman, G. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12543-6 · Cited by 47
Self-citationCarballo‐Jane, E., Pandit, S., Santoro, J. C., Freund, C. M., Luell, S., Harris, G., Forrest, M. J., & Sitlani, A. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.11.012 · Cited by 42
Barrett, T. J., Vig, E., & Vedeckis, W. V. (1996) · Biochemistry · doi:10.1021/bi960058j · Cited by 40
Zhou, F. (1996) · Molecular Endocrinology · doi:10.1210/me.10.3.306 · Cited by 40
Interaction and Functional Interference of Glucocorticoid Receptor and SOCS1
Haffner, M. C., Jurgeit, A., Berlato, C., Geley, S., Parajuli, N., Yoshimura, A., & Doppler, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801041200 · Cited by 35
Roach, S. L., Higuchi, R. I., Adams, M. E., Liu, Y., Karanewsky, D. S., Marschke, K. B., Mais, D. E., Miner, J. N., & Zhi, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.05.029 · Cited by 35
Genetic Dissection of Glucocorticoid Receptor Function in the Mouse Brain
Erdmann, G., Berger, S., & Schütz, G. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01717.x · Cited by 34
Zhou, J., Oakley, R. H., & Cidlowski, J. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0273 · Cited by 26
Janka-Junttila, M., Moilanen, E., Hasala, H., Zhang, X., Adcock, I. M., & Kankaanranta, H. (2006) · Journal of Inflammation · doi:10.1186/1476-9255-3-10 · Cited by 26
Mirshahpanah, P., Döcke, W., Merbold, U., Asadullah, K., Röse, L., Schäcke, H., & Zollner, T. M. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00597.x · Cited by 23
Uings, I., & Farrow, S. N. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.003 · Cited by 22
Cell Type-Dependent Divergence of Transactivation by Glucocorticoid Receptor Ligand.
Tanigawa, K., Tanaka, K., Nagase, H., Miyake, H., Kiniwa, M., & Ikizawa, K. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1619 · Cited by 18
Donet, E., Bosch, P., Sanchís, A., Bayo, P., Ramírez, Á., Cascallana, J. L., Bravo, A., & Paloma, P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0284 · Cited by 16
Therapeutic implications of the nuclear factor-kappaB/nuclear receptor cross-talk
Gossye, V., Haegeman, G., & Bosscher, K. D. (2008) · Frontiers in bioscience · doi:10.2741/2997 · Cited by 12
Cited by
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619
A General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592
“Although the inactive receptor usually resides in the cytoplasm, constant GR shuttling between the nucleus and the cytoplasm has been reported also in the absence of glucocorticoids (Savory et al., 1999; De Bosscher and Haegeman, 2009).”
BackgroundReddy, T. E., Pauli, F., Sprouse, R. O., Neff, N. F., Newberry, K. M., Garabedian, M. J., & Myers, R. M. (2009) · Genome Research · doi:10.1101/gr.097022.109 · Cited by 543
Metadata
- Authors
- De Bosscher, K., & Haegeman, G.
- Affiliations
- Laboratory of Eukaryotic Gene Expression and Signal Transduction, Department of Physiology, Ghent University, 9000 Gent, Belgium
- Ghent University (BE)
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-03-01
- Volume
- 23
- Issue
- 3
- Pages
- 281-291
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC5428155
- OpenAlex
- W2092900546
- Cited by
- 284
- References
- 133
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 2 · 2023: 14 · 2022: 13 · 2021: 6 · 2020: 8 · 2019: 10 · 2018: 11 · 2017: 17 · 2016: 15 · 2015: 15 · 2014: 20 · 2013: 30 · 2012: 22
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Universiteit Gent
- Vlaamse regering
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoids, anti-inflammatory mechanism, glucocorticoid receptor, nuclear receptor cofactors, chromatin regulation, gene transcription, glucocorticoid adverse effects, cell type-specific gene regulation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Gene Expression Regulation, Glucocorticoids, Humans, Immunosuppressive Agents, Models, Biological, Receptors, Glucocorticoid, Repressor Proteins, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.